Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam Premedication for Opioid-induced Mask Ventilation Difficulty
NCT05369819Phase 4Completed
- Sponsor
- Karaman Training and Research Hospital
- Start
- May 2022
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of midazolam in Difficult mask ventilation (DMV) (2 arms), sponsored by Karaman Training and Research Hospital. Primary endpoint: Difficulty of mask ventilation (Warters grading scale). Started May 2022; status: completed.
02
Drugs
midazolam
03
Conditions
Difficult mask ventilation (DMV)
Beyond the preview
Go deeper on NCT05369819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05369819.